Oseltamivir phosphate for oral suspension

oseltamivir phosphate · Oryza Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Oseltamivir phosphate for oral suspension, covering 2017-10-31 to 2024-07-02. Get the full timeline:

Most recent: FDA Approved: OSELTAMIVIR PHOSPHATE FOR ORAL SUSPENSION — Original Application (Oryza Pharmaceuticals Inc.)